StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock.

According to Vanda Research, the chip giant saw nearly $30 billion in inflows during the year. That handily beats out the SPDR S&P 500 ETF (SPY) and Tesla (TSLA). In the video above, Morning Brief ...

StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) in a report released on ...

The result: The United Nations says that, at best, it will be able to raise enough money to help about 60% of the 307 million people it predicts will need humanitarian aid next year. That means at ...

Our team dishes on cowboycore, oversized trousers, Ellie the Elephant, the sickest fits they wore this year, and the hottest ...

Zelensky targets diplomatic end to Putin’s war and hints at role for foreign troops - Ukrainian president says Kyiv wants an ...

Currently, Vanda Bharat Express is the fastest train in India which ... United States approves possible Rs 144133022870 sale of helicopter equipment, support for MH-60R Seahawk, it can... By clicking ...

The year 2024 has been a mixed ride for the biotech industry. It started on a positive note, attracting investors’ attention in areas with great commercial potential, like obesity, immunology and gene ...

Only show cars that can be delivered to me. Please enter your postal code in order to show cars that can be delivered to you.

Hi, I found your property listing on www.srx.com.sg and would like more information. Please send me more details. Thank you.